Vaccination with a low dose of BCG or BCG∆BCG1419c protects against short-term Mycobacterium tuberculosis HN878 infection in male CB6F1 mice
Introduction: Tuberculosis (TB) causes approximately 1.5 million deaths worldwide and 9 million new cases each year. Vaccination with Mycobacterium bovis Bacillus Calmette-Guerin (BCG) is effective in controlling severe forms of TB in childhood, with limited efficacy in preventing lung disease in ad...
Saved in:
| Main Authors: | Jorge Barrios-Payán, Cristian A. Segura-Cerda, Dulce Mata-Espinosa, Helle Bielefeldt‑Ohmann, Rogelio Hernández-Pando, Mario A. Flores-Valdez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Permanyer
2025-07-01
|
| Series: | Revista Médica del Hospital General de México |
| Subjects: | |
| Online Access: | https://www.hospitalgeneral.mx/frame_eng.php?id=261 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors influencing the efficacy of Bacille Calmette-Guérin (BCG) vaccine
by: Lwandile Bukula, et al.
Published: (2025-03-01) -
BCG and beyond: unlocking new frontiers in TB vaccine development
by: Aishwarya Shaji, et al.
Published: (2025-07-01) -
Correction: BCG and beyond: unlocking new frontiers in TB vaccine development
by: Aishwarya Shaji, et al.
Published: (2025-08-01) -
A clinical case of disseminated BCG infection with a fatal outcome
by: S. M. Kharit, et al.
Published: (2024-04-01) -
Local complications and lymphadenitis after BCG–M vaccination in children – сhoosing the right tactics
by: M. E. Lozovskaja, et al.
Published: (2021-07-01)